The American Academy of Dermatology has released new guidelines for the management of primary squamous cell carcinoma and basal cell carcinoma.

FDA Alerts

FDA Alerts
Thursday, December 21, 2017
The FDA has approved a treatment for intravenous use for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or metastatic disease who have undergone complete resection.
FDA Alerts
Friday, November 10, 2017
The FDA has expanded approval of a therapy for anaplastic large cell lymphoma.
FDA Alerts
Monday, July 24, 2017
The US Food and Drug Administration had granted expanded approval of a melanoma drug to include pediatric patients.
FDA Alerts
Friday, March 24, 2017
The FDA recently granted accelerated approval for the treatment of metastatic Merkel cell carcinoma (MCC) in adults and pediatric patients 12 years of age and older, including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare and aggressive form of skin cancer.

News

News
Monday, January 8, 2018
Keratinocyte carcinoma is the most common cancer in the United States. In a recent study, researchers examined the effectiveness of a single course of topical cream at preventing this cancer.
News
Wednesday, January 3, 2018
In very elderly patients, less aggressive skin cancers on the face might not always need to be treated, a new study suggests.
News
Friday, December 22, 2017
The FDA has granted priority review of a combination therapy for patients with advanced melanoma.
News
Friday, December 8, 2017
Researchers recently evaluated the risk of non-melanoma skin cancer in patients who take hydrochlorothiazide.

Research in Review

Research in Review
Friday, November 24, 2017
This article describes a case with an uncommon and often misdiagnosed clinical presentation.
Research in Review
Monday, September 18, 2017
This case discusses the diagnosis and treatment of an older woman presenting with a large mass on her left cheek.
Research in Review
Monday, May 22, 2017
New funding will allow researchers to expand the scope of their work in skin cancer.  
Research in Review
Friday, September 9, 2016
In this case, a fractional CO2 laser is used in the treatment of multiple basal cell carcinomas in a patient.